Douglas E. Murphy

926 citations

16 papers · 372 · h-index 10

Impact in

Organic Chemistry top 10%
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
- Chemical Synthesis and Reactions
Hepatology top 10%
- Hepatitis C virus research

Papers in

Organic Chemistry 12
- Quinazolinone synthesis and applications 5
- Synthesis and Reactivity of Heterocycles 3
- Synthesis and Biological Evaluation 3
- Synthesis and Characterization of Heterocyclic Compounds 2
Molecular Biology 10
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Chemical Synthesis and Analysis 3

Co-authors: Yuefen Zhou (12 shared papers)Zhongxiang Sun (9 shared papers)V. Gregor (4 shared papers)Benjamin K. Ayida (5 shared papers)Jamie M. Froelich (3 shared papers)Daniel Wall (3 shared papers)Stephen E. Webber (6 shared papers)Sarah Fish (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Tetrahedron Letters (2 papers)Synthesis (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Tetrahedron (1 paper)
Partner nations: United States Denmark

In The Last Decade

Douglas E. Murphy

16 papers receiving 337 citations

Peers

Countries citing papers authored by Douglas E. Murphy

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Murphy more than expected).

Fields of papers citing papers by Douglas E. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Murphy. The network helps show where Douglas E. Murphy may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas E. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas E. Murphy Line = papers co-authored together Douglas E. Murphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Synthesis and SAR of 3,5-diamino-piperidine derivatives: Novel antibacterial translation inhibitors as aminoglycoside mimetics Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou, V. Gregor, Benjamin K. Ayida, Geoffrey C. Winters, Zhongxiang Sun, Douglas E. Murphy, Greg Haley, Dwight Bailey, Jamie M. Froelich, Sarah Fish, Stephen E. Webber, Thomas Hermann, Daniel Wall	2006	119
2	Structure-Guided Discovery of Novel Aminoglycoside Mimetics as Antibacterial Translation Inhibitors Antimicrobial Agents and Chemotherapy ·Yuefen Zhou, V. Gregor, Zhongxiang Sun, Benjamin K. Ayida, Geoffrey C. Winters, Douglas E. Murphy, Klaus B. Simonsen, Dionisios Vourloumis, Sarah Fish, Jamie M. Froelich, Daniel Wall, Thomas Hermann	2005	42
3	Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists Journal of Medicinal Chemistry ·Anthony Ling, Yufeng Hong, Javier González, V. Gregor, Alex Polinsky, Atsuo Kuki, Shenghua Shi, Kimberly Teston, Douglas E. Murphy, John W. Porter, Dan Kiel, James Lakis, Kenna Anderes, John M. May, Lotte Bjerre Knudsen, Jesper Lau	2001	37
4	Novel parallel synthesis of N-(4-oxo-2-substituted-4H-quinazolin-3-yl)-substituted sulfonamides Tetrahedron Letters ·Yuefen Zhou, Douglas E. Murphy, Zhongxiang Sun, V. Gregor	2004	36
5	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou, Stephen E. Webber, Douglas E. Murphy, Lian‐Sheng Li, Peter S. Dragovich, Chinh Van Tran, Zhongxiang Sun, Frank Ruebsam, Amit Shah, Mei Tsan, Richard E. Showalter, Rupal Patel, Bin Li, Qiang Zhao, Qing Han, Thomas Hermann, Charles R. Kissinger, Laurie A. LeBrun, Maria V. Sergeeva, Leo Kirkovsky	2008	29
6	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Julie Blazel, David A. Ellis, Qing Han, Ruhi Kamran, Charles R. Kissinger, Laurie A. LeBrun, Lian‐Sheng Li, Douglas E. Murphy, Michael Noble, Rupal Patel, Frank Ruebsam, Maria V. Sergeeva, Amit Shah, Richard E. Showalter, Chinh Van Tran, Mei Tsan, Stephen E. Webber, Leo Kirkovsky, Yuefen Zhou	2008	22
7	Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters Tetrahedron Letters ·Douglas E. Murphy, Peter S. Dragovich, Benjamin K. Ayida, Thomas M. Bertolini, Lian‐Sheng Li, Frank Ruebsam, Nebojša Stanković, Zhongxiang Sun, Jingjing Zhao, Yuefen Zhou	2007	21
8	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou, Lian‐Sheng Li, Peter S. Dragovich, Douglas E. Murphy, Chinh Van Tran, Frank Ruebsam, Stephen E. Webber, Amit Shah, Mei Tsan, April M. Averill, Richard E. Showalter, Rupal Patel, Qing Han, Qiang Zhao, Thomas Hermann, Charles R. Kissinger, Laurie A. LeBrun, Maria V. Sergeeva	2008	21
9	Regiospecific synthesis of 1,5-disubstituted-1H-pyrazoles containing differentiated 3,4-dicarboxylic acid esters via Suzuki coupling of the corresponding 5-trifluoromethane sulfonates Tetrahedron ·Peter S. Dragovich, Thomas M. Bertolini, Benjamin K. Ayida, Lian‐Sheng Li, Douglas E. Murphy, Frank Ruebsam, Zhongxiang Sun, Yuefen Zhou	2006	16
10	Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou, Chun Yuen Chow, Douglas E. Murphy, Zhongxiang Sun, Thomas M. Bertolini, Jamie M. Froelich, Stephen E. Webber, Thomas Hermann, Daniel Wall	2008	9
11	Efficient synthesis of (1R,2S) and (1S,2R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form Tetrahedron Asymmetry ·Peter S. Dragovich, Douglas E. Murphy, Kimkim Dao, Sun Hee Kim, Lian‐Sheng Li, Frank Ruebsam, Zhongxiang Sun, Chinh Van Tran, Alan X. Xiang, Yuefen Zhou	2008	6
12	Last Futures: Nature, Technology and the End of Architecture Douglas E. Murphy	2016	5
13	Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation Antiviral Research ·Yonglei Zhou, L LI, S. E. Webber, Peter S. Dragovich, Douglas E. Murphy, Công Anh Trần, Frank Ruebsam, Amit Shah, Mei Tsan, Richard E. Showalter	2007	3
14	Efficient Large-Scale Synthesis of 2-Amino-5-methanesulfonylaminobenzenesulfonamide Synthetic Communications ·Peter S. Dragovich, Douglas E. Murphy, Chinh Van Tran, Frank Ruebsam	2008	3
15	Regiospecific Synthesis of Novel 6-Amino-5-hydroxypyridazin-3(2H)-ones Synthesis ·Peter S. Dragovich, Julie Blazel, Kimkim Dao, David Ellis, Lian‐Sheng Li, Douglas E. Murphy, Frank Ruebsam, Chinh Van Tran, Yuefen Zhou	2008	2
16	Synthesis of New Pyridazinone Derivatives: 2,6-Disubstituted 5-Hydroxy-3(2H)-pyridazinone-4-carboxylic Acid Ethyl Esters Synthesis ·Yuefen Zhou, Lian-Sheng Li, Jingjing Zhao, Peter S. Dragovich, Nebojša Stanković, Thomas M. Bertolini, Douglas E. Murphy, Zhongxiang Sun, Chinh Tran, Benjamin K. Ayida, Frank Ruebsam, Stephen E. Webber	2007	1

About Douglas E. Murphy

Douglas E. Murphy is a scholar working on Organic Chemistry, Molecular Biology, Infectious Diseases, Hepatology and Ecology, having authored 16 papers that have together received 372 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Synthesis and Reactivity of Heterocycles (3 papers), HIV/AIDS drug development and treatment (3 papers), Synthesis and Biological Evaluation (3 papers), Hepatitis C virus research (3 papers), Chemical Synthesis and Analysis (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Organic Chemistry (228 citations), Hepatology (53 citations), Molecular Biology (162 citations), Computational Theory and Mathematics (37 citations) and Infectious Diseases (35 citations). Douglas E. Murphy has collaborated with scholars based in United States and Denmark. Frequent co-authors include Yuefen Zhou, Zhongxiang Sun, V. Gregor, Benjamin K. Ayida, Jamie M. Froelich, Daniel Wall, Stephen E. Webber, Sarah Fish, Geoffrey C. Winters and Peter S. Dragovich. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Synthesis, Antimicrobial Agents and Chemotherapy and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Douglas E. Murphy

Impact in

Papers in i

In The Last Decade

Douglas E. Murphy

Peers

Countries citing papers authored by Douglas E. Murphy

Fields of papers citing papers by Douglas E. Murphy

All Works

About Douglas E. Murphy

Explore authors with similar magnitude of impact

Papers in